Classification of brain tumors
The basic division of a brain tumor is on the primary and secondary. Primary tumors are those arising from the brain parenchyma in the skull while secondary tumors of the brain are metastases, which occur by joining of malignant tumor cells of distant organs at their arrival into the brain. Primary tumors are most commonly seen in children (first decade of life). In adults, incidence increases with age and for persons over 65 years of age is 18 per 100 000. Primary tumors can be divided into malignant and benign, although essentially all brain tumors are malignant due to their specific location. The difference between benign and malignant brain tumors is in their growth rate, partly in the way of growth and the percentage of recovery. Benign brain tumors grow slowly, putting pressure on the surrounding parts of the brain, while malignant tumors grow rapidly and permeate (infiltrate) the brain. 
. METASTATIC TUMORS
There are over 80 types of tumors that can grow inside the skull and cause brain damage. However, in adults 5 types of tumors is encountered in over 90% of cases. These are: 1. Gliomas -this includes astrocytoma, oligodendroglioma, anaplastic astrocytoma and glioblastoma 2. Meningioma 3. Neuroma 4. Pituitary adenoma 5. Brain metastases from distant malignant tumors.
Specificity of tumor types 1.6.1 Gliomas
These are the most common brain tumors. They make up 50% of the total number of brain tumors. Annually in the United States they affect 7 people per 100 000. More frequent in men than women. Most often when grow permeate the surrounding brain structures. They have great potential to become malignant. According to the degree of malignancy have three or four stages. In the first stage healing is likely. Already in the second stage the survival for more than 5 years is 50-75%. In 3 rd and 4 th stage survival is even shorter. After the surgery is always indicated radiation and is often used is chemotherapy.
Meningiomas
Meningiomas are mostly benign tumors. 1-2% is malignant ones. Make up 15% to 20% of all tumors and 25% of brain tumors. Annually in the United States are affected 2 per 100 000 people. They are more often in women than men. Increase with the depletion of brain pressing the surrounding parts of the brain, nerves and blood vessels.
Fig. 1. Meningioma
The treatment is usually radical, surgical excision.
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Neuroma
Arise from cells that are found in nerves. Constitute 5-10% of all brain tumors. Every year in United States 3000 new cases is diagnosed. The incidence is 1 in 100 000 people. The most common sites are the nerves of hearing and balance (neurinoma, schwanoma vestibullaris nerves, tumor of angulo pontocerebellaris). Because of that usually start with hearing impairment and dizziness. This symptom may remain for years. Later it can cause numbness and facial pain (symptomatic trigeminal neuralgia), bending of the face due to facial nerve damage, weakness of limbs due to pressure on the brain stem, hydrocephalus, etc. It is usually possible to remove completely these tumors. Alternative therapy, particularly in case of small neuromas, is the stereotaxic radiation.
Pituitary adenoma
These are tumors that arise from the pituitary gland, glands of internal secretion. Make 14% of all brain tumors. Can secrete excessive hormones and then are usually diagnosed earlier, while still small. Depending on the hormone secreted by the patient will develop hyperprolactinemia, Cushing's disease, etc. If they secrete hormones in the gland tumor can rather grow until the first symptoms. Large adenomas are first manifested by visual disturbances. Later it can occur: reduced secretion of pituitary hormones, strabismus, double vision, frequent urination, difficulty in walking and mental symptoms and signs of hydrocephalus.
Brain metastases
Brain metastases are the complications of systemic dissemination of primary tumors. Malignant primary tumors of the blood and lymphoma reach distant organs (usually the lungs, liver and brain), multiply and produce a new tumor. Brain metastases are the most common intracranial neoplasm in adults. Constitute about 12-27% of total CNS neoplasms. They occur in about 20-40% of cancer patients. The incidence of brain metastases is increasing. Every year in the U.S. are diagnosed between 98 000 and 170 000 new cases of brain metastases. In brain usually metastasize the tumors of the lungs (50%), breast cancer (15%), and malignant melanoma (10%). Eighty percent of brain metastases were located in the cerebral hemispheres, 15% in the cerebellum, and 5% in the brain stem. Survival of patients with brain metastases are treated only symptomatic therapy for 1-2 months, whole brain irradiation 3-6 months, a surgical procedure, and whole brain irradiation for 8-9 months. Brain tumor surgery involves craniotomy (opening of the skull), reaching the tumors and its complete (ablation) or partially (reduction) removal. The tumor must be separated from the surrounding structures. This is impossible if the tumor grows by infiltration (malignant tumors). In as much as a benign tumor growth in a long time and become big, it really press, and want to stick to surrounding structures. Then is often impossible to separate them and preserve function. This is the main reason why it is important to diagnose the tumor as early as possible, while they have smaller sizes. Mortality related to surgery is generally less than 1% and is usually caused by worsening of other diseases. Neurological damage associated with surgery depends on the size and tumor location. In most cases is less than 1%. In difficult localizations and large tumors occurs in 20% of patients. Accurate radiation can be achieved by using radio surgical methods, Gamma Knife and Linac. Thus precise radiation can stop tumor growth, if not already 2.5 cm in diameter and are very close to the structure of the brain that cannot tolerate radiation. Also they can stop the growth of small parts of tumors that were left behind after surgery. This method has not yet begun to be applied in our country. In developed countries it is for a long time the standard treatment. Chemotherapy usually today involves use of Tamodal. According to recent studies conducted in Australia, chemotherapy has helped in only 2% of cases suffering from cancer.
Diagnosis of brain tumors

Problem formulation
This raises the question of the incidence of brain tumors at the Neurology Clinic Sarajevo from January 1 st 2006 -December 31 st 2009. divided into malignant and benign although because the specifics of their location it is difficult to talk about benign brain tumors. Its growth and pressure on surrounding structures causing increased intracranial pressure, headaches, vomiting, seizures and neurological disturbances. Brain tumors constitute 9-10% of all tumors. They are more common in men than in women. Are quite common in the child's age, where have second place in relation to other tumors. It is usually diagnosed at age of 5-10 years, mostly astrocytoma (40%) and medulloblastoma (20%). In older populations, the incidence of tumors increases with age and is highest after age of 60. The most common tumors are gliomas and make up 50% of brain tumors, and meningiomas, which represent 25% of brain tumors. 
Secondary goals
1. Conduct analysis of age and sex structure of patients with brain tumors. 2. To determine the incidence of tumors in relation to the type (histological structure). 3. To determine the incidence of tumors in relation to the localization. 4. To determine the prevalence of general and focal symptoms of brain tumors. 5. To determine the incidence of brain metastases. 6. To determine the incidence of brain tumors in relation to the total number of hospitalized patients. 
Hypothesis
Material and methods
Study design
The study was conducted at Clinic of Neurology, Clinical Centre of Sarajevo University. Performed is a retrospective study that included 33 patients with brain cancer, aged between 28 and 79 years, who were treated at the Neurology Clinic Sarajevo from January 1 st 2006 -December 31 st 2009.
Methods of data collection
Was reviewed medical records and history of illness of patients treated at the aforementioned Clinic. All patients were processed in an identical manner using the following questionnaire: -General information about the patient: 
Results
Demographic analysis by gender
Of the total number of respondents (N = 33), 12 (36.4%) were male and 21 (63.6%) were female. It was found that there was a statistically significant difference in the higher risk of brain tumors for the female population. Table 2 . Presentation of sex structure of respondents in CCUS by years of research.
Gender
Of the total number of respondents in 2006 (N=8), three of them (37.5%) were male and 5 (62.5%) female. Total number of respondents was in 2007 -10 (N=10) and all were female. Of the total number of patients with brain tumors in 2008 (N=6), 3 (50%) were male and the remaining 3 (50%) female. In 2009 the total number of respondents was 9, of which 6 (66.7%) males and 3 (33.3%) female. Statistical analysis using chi-square test revealed statistically significant differences in gender distribution according to year of study (p <0.05). Since tumors that were primarily formed in another places in the body in relation to the total number of patients (N=33), are represented by adenocarcinoma of the lung with 2 (6.7%), and periurethral adenoma with 1 (3.3%), malignant melanoma with 1 (3.3%) and one patient with sarcoma (3.3%). In one case from 2007 unknown is the primary localization of the brain tumor. 
Demographic analysis according to age of respondents
Year of the hospitalization
Analysis of the localization of brain tumors
From 33 analyzed patients showed that the brain tumors are located mostly in the cerebellum (21%), then frontoparietal (18.1%) in the brain stem (15.1%), parietal (12%). In sphenoid sinus are located 9.1% of tumors. The frontal, occipital, and parietoccipital in the cavernous sinus are located 6.1% of the tumors. Statistical analysis of the incidence of tumors in relation to their location, by years of research, showed no statistically significant difference. 
Discussion
In a study conducted at the Neurology Clinic Sarajevo from January 1 st 2006 -December 31 st 2009, it was found that the incidence of brain tumors is less than 1%, and there is no significant statistical difference in the incidence of tumors by years of research, except when it comes to the gender distribution of patients. which obtained data using the California Cancer Registry, showed that the incidence of this disease is less than 1% (0.07%) and that 59.5% of patients were in age from 20 to 64 years, of which 56.5% were women. 56.4% of tumors were benign, malignant 37.1%, and for 6.5% tumors it was difficult to determine malignant potential. The most common benign tumors were meningiomas (51.6%), and malignant tumors, gliomas (52.5%). Previous two studies and research at the Clinic of Neurology, which are included in this survey, confirming the dependence of the frequency of brain tumors by sex on the incidence of brain tumors in relation to the type of tumors. The research at Clinic of Neurology, which is included in this study, has registered 10 (30%) of 33 patients with brain metastases. In four brain metastases was not found listed species or location of primary tumors in the patient's medical history. Primary brain tumors of the other 6 metastases were adenocarcinoma of the lung metastases (N=2), malignant melanoma (N=1), periurethral adenoma (N=1), sarcoma (N=1), and breast cancer (N=1). According to world literature metastases make 12-25% of brain tumors (1). The survey conducted by Teletovic and associates, in Istria (Croatia), at the Neurological Department of the General Hospital in Pula, in the period from 1986 to 2000, it was found that 56.87% were primary, mostly malignant tumors, 43.13% brain metastases. Thus a large number of brain metastases in Istria are explained by stress caused by war during nineties in Croatian territory, and weakening of immunity, and increased use of cigarettes and alcohol. According to a retrospective study, the incidence of brain tumors at the Department of Neurology CCUS, for the period from January 1 st 1990 to December 31 st 1999, which conducted Alajbegovic and Hrnjica with associates, 36% of patients (N=105) had brain metastasis.
Research at the Clinic of Neurology, which is included in this study showed that the average age of patients with brain tumor is 53.6 years with the youngest patient aged 28 and the oldest aged 79 years. According to a study conducted by Srdjan and Sinisa Telarovic with associates, found the illness mostly in the population aged 50-59 years. A study conducted by Peter D. and associates in Cyprus, confirmed that the brain tumors usually occur in the population of at age 50-69 years and in 40% of cases. In 33 analyzed patients showed that the brain tumors are located in the cerebellum (21%), then frontal parietal (18.1%) in the brain stem (15.1%) and parietal (12%). In sfenoidal sinus was located 9.1%tumors. The frontal, occipital, and partial occipital in the cavernous sinus was located 6.1% tumors. In other words, most of the tumors was located in the cerebral hemispheres, and in the cerebellum, and then in the brain stem. This coincides with a study by Peter D. in Cyprus by which 34.8% tumors are located in the cerebral hemispheres, 4.7% in the cerebellum, 2% in the brain stem and 2% in the spinal cord. For the other 48% tumors location was not specified. According to a study by Sinisa and Srdjan Teletovic, 43% tumors were localized in the cerebral hemispheres, 15.2% in the cerebellum and the rest of the tumors were located in the brain stem and spinal cord.
